You have 9 free searches left this month | for more free features.

City

Auckland (2)

Adelaide (1)

Albury (1)

Melbourne (1)

Murdoch (1)

Perth (1)

Saint Albans (1)

Sydney (1)

Westmead (1)

Condition

Bioequivalence (1)

Hepatocellular Carcinoma (1)

Renal Cell Carcinoma (1)

Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Apollomics (Australia) Pty. Ltd. (1)

Apollomics Inc. (1)

Collaborator

Apollomics Inc. (formerly CBT Pharmaceuticals, Inc.) (1)

Novotech (Australia) Pty Limited (1)

Intervention

apl-101 (2)

apl-501 (1)

nivolumab (1)

plb-1001 (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

apl-101

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Bioequivalence Trial in Auckland (APL-101, PLB-1001)

Recruiting

Bioequivalence

APL-101
PLB-1001

Auckland, New Zealand

New Zealand Clinical Research

Jun 13, 2022

Hepatocellular Carcinoma, Renal Cell Carcinoma Trial in Australia, New Zealand (APL-501, APL-101, Nivolumab)

Terminated

Hepatocellular Carcinoma
Renal Cell Carcinoma

APL-501
+2 more

Albury, New South Wales, Australia
+8 more

May 3, 2022